FDA Submits Proposed Information Collection for OMB Review and Clearance

Summary

The Food and Drug Administration (FDA) has submitted a proposed data collection to the Office of Management and Budget (OMB) for review and approval under the Paperwork Reduction Act of 1995, as part of its efforts to enhance postmarketing adverse drug experience reporting.